eGenesis raises $191 million in Series B funding
eGenesis, a biotechnology company developing engineered organs to address the global organ shortage, raised $191 million in Series B funding. Lux Capital led the investment … Read more
ARCH Ventures
eGenesis, a biotechnology company developing engineered organs to address the global organ shortage, raised $191 million in Series B funding. Lux Capital led the investment … Read more